Mednax Inc $ 25.91 0.53 (2.09%)
On watch
Volume:
1,512,111
Avg Vol (1m):
1,146,179
Market Cap $:
2.18 Bil
Enterprise Value $:
4.10 Bil
P/E (TTM):
0.00
P/B:
1.47
| Earnings Power Value | ||
| Net Current Asset Value | ||
| Tangible Book | ||
| Projected FCF | ||
| Median P/S Value | ||
| DCF (FCF Based) | ||
| DCF (Earnings Based) | ||
|
Price: $25.91 | ||
Manual of Stocks™ Web
Financial Strength | 4/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.05 | ||
| Equity-to-Asset | 0.35 | ||
| Debt-to-Equity | 1.37 | ||
| Debt-to-EBITDA | -2.11 | ||
| Interest Coverage | 3.58 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 0.79 | ||
| Beneish M-Score | -3.03 | ||
Profitability | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 11.36 | ||
| Net Margin % | -39.22 | ||
| ROE % | -55.28 | ||
| ROA % | -26.39 | ||
| ROC (Joel Greenblatt) % | -218.15 | ||
| 3-Year Revenue Growth Rate | 10.4 | ||
| 3-Year EBITDA Growth Rate | -2.4 | ||
| 3-Year EPS without NRI Growth Rate | -6.5 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Forward PE Ratio | 7.4 | ||
| PB Ratio | 1.47 | ||
| PS Ratio | 0.6 | ||
| Price-to-Free-Cash-Flow | 7.3 | ||
| Price-to-Operating-Cash-Flow | 6.32 | ||
| EV-to-EBIT | -3.83 | ||
| EV-to-EBITDA | -4.27 | ||
| EV-to-Revenue | 1.11 | ||
| Shiller PE Ratio | 23.97 | ||
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.93 | ||
| Days Sales Outstanding | 48.95 | ||
| Days Payable | 5.14 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.2 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 0.38 | ||
| Price-to-Median-PS-Value | 0.29 | ||
| Earnings Yield (Greenblatt) % | -26.05 | ||
| Forward Rate of Return (Yacktman) % | 16.89 |